Lucy Scientific Discovery, Inc.
DelistedCIK 1865127fmd_0FBVN9YY95J94KGJMRQQT58ABNManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2020 to Dec 31, 2023, 11 periods
| Line item | FY2022 | FY2023 |
|---|---|---|
| Total revenues | – | 0 |
| Cost of revenue | – | 0 |
| Gross profit | – | 0 |
| Selling, general and administrative | 3 | 6 |
| Total operating expenses | 3 | 6 |
| Impairment of real estate | – | 0 |
| Operating income | (3) | (6) |
| Interest expense | 2 | 2 |
| Other non-operating income (expense) | (2) | (3) |
| Income before taxes | – | (9) |
| Net income | (6) | (9) |